Omnichannel marketing has been heralded as the next frontier in customer engagement, offering a seamless and integrated experience across various channels. The biopharmaceutical industry is no stranger to this trend, with a significant number of the top 100 pharmaceutical companies adopting
In the ever-evolving landscape of pharmaceuticals, the debate over regulatory data protection (RDP) is intensifying. As the Belgian Presidency of the Council of the EU approaches its twilight, policymakers are grappling with how to balance the imperatives of fostering pharmaceutical innovation with
The European Health Data Space (EHDS) marks a significant shift in healthcare within the European Union, profoundly affecting the management and usage of health data. It promises to empower EU citizens with better control over their health information while also improving clinical practices. The
The intersection of precision medicine and artificial intelligence (AI) is ushering in a transformative era, one where healthcare is redefined in its approach and interaction with patients. In a recent inspiring presentation, Dr. Eric Topol shared his insights into a not-so-distant future where AI
In a decisive move to safeguard financial stability and bolster public trust, the United States government has announced a significant intervention in the wake of the Silicon Valley Bank (SVB) failure. Unprecedented Access to Depositor Funds Starting on Monday, former clients of SVB are assured
The digital ecosystem is witnessing a paradigm shift with the introduction of 'data-blind SaaS', a futuristic model poised to overhaul the traditional norms of cloud computing. For years, Software as a Service (SaaS) models have been the linchpin of cloud-based business operations, enabling
